MAM
ORGO icon

Meeder Asset Management’s Organogenesis Holdings ORGO Stock Holding History

Meeder Asset Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-96
Closed – – 1617
2022
Q3 		$0 Sell
96
-868
-90% -$3.92K ﹤0.01% 2299
2022
Q2 		$5K Buy
964
+791
+457% +$4.87K ﹤0.01% 1658
2022
Q1 		$1K Sell
173
-200
-54% -$1.55K ﹤0.01% 2223
2021
Q4 		$4K Buy
373
+37
+11% +$393 ﹤0.01% 903
2021
Q3 		$5K Buy
336
+317
+1,668% +$4.92K ﹤0.01% 1939
2021
Q2 		$0 Sell
19
-1,038
-98% -$19.3K ﹤0.01% 2610
2021
Q1 		$21K Buy
+1,057
New +$14.3K ﹤0.01% 1391
2020
Q4 		– Sell
-2,728
Closed -$10K – 2121
2020
Q3 		$10K Hold
2,728
– – ﹤0.01% 1382
2020
Q2 		$10K Hold
2,728
– – ﹤0.01% 1321
2020
Q1 		$8K Sell
2,728
-291
-10% -$1.25K ﹤0.01% 1621
2019
Q4 		$15K Buy
+3,019
New +$19.1K ﹤0.01% 1437

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Meeder Asset Management's ORGO Position: Q4 2022 in Review

Meeder Asset Management sold out of Organogenesis Holdings (ORGO) in Q4 2022, closing a stake of 96 shares.

Meeder Asset Management first reported a position in ORGO in Q4 2019 and held it in 11 quarters. The position peaked at $21K in Q1 2021. 150 funds tracked by Wall St. Rank hold ORGO as of Q4 2022.

  • Meeder Asset Management reported no remaining Organogenesis Holdings position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 96 Organogenesis Holdings shares in Q4 2022.
  • Meeder Asset Management first reported a position in Organogenesis Holdings in Q4 2019 and held it in 11 quarters.
  • Meeder Asset Management's Organogenesis Holdings position peaked at $21K in Q1 2021.
  • 150 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.